Evidence map›Paper›PMID 33502634›Full record

ReviewBiogerontology2021

Aging and age-related diseases: from mechanisms to therapeutic strategies.

Zhe Li, Zhenkun Zhang, Yikun Ren, Yingying Wang, Jiarui Fang, Han Yue, Shanshan Ma, Fangxia Guan

Open access · bronzeAbstract readReview
In one paragraph

Review in Biogerontology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 324 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
324citing papers in PubMed, 5 pooled it
34.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

324 citing papers in PubMed, 5 syntheses or guidelines pooled it, 592 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Trial
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Postbiotic metabolites fromExperimental and therapeutic medicine · 2026
    Article
  17. Article
  18. Article
  19. Review
  20. A genomic structural equation modelling analysis of the shared genetic architecture of the aging spine.European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society · 2026
    Article

264 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Zhe LiSchool of Life Sciences, Zhengzhou University, Zhengzhou, 450001, Henan, China.
Zhenkun ZhangSchool of Life Sciences, Zhengzhou University, Zhengzhou, 450001, Henan, China.
Yikun RenSchool of Life Sciences, Zhengzhou University, Zhengzhou, 450001, Henan, China.
Yingying WangSchool of Life Sciences, Zhengzhou University, Zhengzhou, 450001, Henan, China.
Jiarui FangSchool of Life Sciences, Zhengzhou University, Zhengzhou, 450001, Henan, China.
Han YueStem Cell Research Center, Henan Provincial People's Hospital, Zhengzhou, 450003, Henan, China.
Shanshan MaSchool of Life Sciences, Zhengzhou University, Zhengzhou, 450001, Henan, China. mashanshan84@163.com.
Fangxia GuanSchool of Life Sciences, Zhengzhou University, Zhengzhou, 450001, Henan, China. guanfangxia@126.com.ORCID http://orcid.org/0000-0002-8415-0959
Zhengzhou University · CNHenan Provincial People's Hospital · CN

Funding

Central Plains Thousand People Plan of Henan Province 204200510013National Natural Science Foundation of China (CN) U2004201Training plan for young excellent teachers in Colleges and Universities of Henan 2020GGJS008
6 · The paper itself

Abstract

Aging is a physiological process mediated by numerous biological and genetic pathways, which are directly linked to lifespan and are a driving force for all age-related diseases. Human life expectancy has greatly increased in the past few decades, but this has not been accompanied by a similar increase in their healthspan. At present, research on aging biology has focused on elucidating the biochemical and genetic pathways that contribute to aging over time. Several aging mechanisms have been identified, primarily including genomic instability, telomere shortening, and cellular senescence. Aging is a driving factor of various age-related diseases, including neurodegenerative diseases, cardiovascular diseases, cancer, immune system disorders, and musculoskeletal disorders. Efforts to find drugs that improve the healthspan by targeting the pathogenesis of aging have now become a hot topic in this field. In the present review, the status of aging research and the development of potential drugs for aging-related diseases, such as metformin, rapamycin, resveratrol, senolytics, as well as caloric restriction, are summarized. The feasibility, side effects, and future potential of these treatments are also discussed, which will provide a basis to develop novel anti-aging therapeutics for improving the healthspan and preventing aging-related diseases.

Indexed as

AgingLongevityCaloric RestrictionCellular SenescenceHumansLife ExpectancyAge‐related diseasesAgingAnti‐aging drugsHallmarks of aging

Identifiers

PMID33502634
PMCPMC7838467
OpenAlexW3123843327

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.